Emerging research suggests that effective microbiome support, such as butyric acid supplementation, can have a significant impact on cancer treatment outcomes by directly affecting drug metabolism.
A growing body of literature suggests that CBD is a well-tolerated adjunct therapy that will aid recovery and make patients more comfortable during and after chemotherapy.
Evidence suggests that butyric acid supplementation can provide the critical support needed to improve the health of the gut microbiome and help patients optimize well-being.
Many nutritional supplements have historically suffered from poor bioavailability, but new technologies are paving the way for improved therapeutic efficacy and giving patients a fresh chance to heal.
For those who are interested in integrating cannabinoids in their treatment plans, understanding these differences between CBD and THC is essential to optimize therapeutic benefits while minimizing risk.
For many, combining existing Crohn’s disease medications with advanced nutraceuticals may allow for enhanced symptom remission and better long-term health without additional side effects.
In part two of our interview, Walter Crinnion expands his discussion on the most pernicious environmental toxins and shares practical strategies for mitigating their impact.
In the first of a two-part interview, Walter Crinnion shares his thoughts on the most pressing environmental hazards of our time and how members of the public can protect themselves from common toxins.
As the dangers of oxidative stress become increasingly evident, there is reason to believe that lowering this stress via glutathione supplementation could help patients optimize well-being.
Emerging research suggests that curcumin can enhance weight loss even in patients who have previously struggled with conventional weight loss efforts due to metabolic disorders.